Status:
COMPLETED
Coenzyme Q10 in Relation to the Antioxidative Vitamins, Oxidative Stress and Inflammation in Coronary Artery Disease Patients During Statin Therapy
Lead Sponsor:
Taichung Veterans General Hospital
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
20-90 years
Phase:
PHASE2
PHASE3
Brief Summary
Cardiovascular disease (CVD) is the leading cause of Taiwan. American Heart Association (AHA) indicated that CVD patients with Statin therapy would decrease the recurrence of CVD. The goal for lipid l...
Eligibility Criteria
Inclusion
- CAD patients is identified by cardiac catheterization as having at least 50% stenosis of one major coronary artery and under statin therapy.
Exclusion
- age \< 18 years old
- pregnancy women
- taking antioxidant vitamins supplements
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT01424761
Start Date
August 1 2011
End Date
March 1 2013
Last Update
June 12 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taichung Verterans General Hospital
Taichung, Taiwan